Skip to main content

Table 2 General characteristics of the human study population

From: Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis

Subgroup

Control

NAFL

NASH

CHB without NASH

CHB with NASH

n

23

12

30

25

14

Age

39.91 ± 1.19

42.33 ± 3.57

38.20 ± 2.66

36.76 ± 2.59

39.00 ± 3.75

Male (%)

14 (60.87%)

8 (66.67%)

18 (60.00%)

16 (64.00%)

9 (64.29%)

Waistline

80.96 ± 1.32

89.17 ± 1.19**

92.34 ± 1.43**

80.38 ± 3.28

90.00 ± 1.68**

BMI

23.80 ± 0.52

26.74 ± 0.85**

27.73 ± 0.61**

22.61 ± 0.64

26.25 ± 0.53**

TB

15.63 ± 0.79

13.48 ± 1.46

19.06 ± 3.32

25.30 ± 5.00

12.98 ± 0.85

DB

2.53 ± 0.19

4.86 ± 0.69**

9.43 ± 3.03*

11.15 ± 3.63*

3.97 ± 0.40**

ALP

69.30 ± 3.87

78.98 ± 9.89

95.38 ± 7.60**

84.73 ± 8.66

96.01 ± 15.22*

γ-GT

25.47 ± 4.51

31.76 ± 4.22

157.26 ± 56.40*

82.35 ± 20.69*

46.39 ± 9.02

ALT

24.17 ± 2.23

43.94 ± 5.70**

99.55 ± 11.87**

113.91 ± 30.18**

59.13 ± 9.79**

AST

21.17 ± 0.93

24.13 ± 1.54

60.32 ± 6.20**

60.93 ± 12.75**

41.73 ± 7.23**

TC

4.60 ± 0.18

4.38 ± 0.26

4.84 ± 0.19

3.75 ± 0.17**

5.43 ± 0.30*

TG

1.37 ± 0.16

1.51 ± 0.24

2.05 ± 0.22*

1.25 ± 0.15

2.70 ± 0.83*

HDL

1.25 ± 0.04

1.30 ± 0.07

1.17 ± 0.06

1.12 ± 0.06

1.31 ± 0.08

LDL

2.83 ± 0.15

2.78 ± 0.09

2.89 ± 0.13

2.32 ± 0.12*

2.93 ± 0.22

FPG

5.00 ± 0.14

6.02 ± 0.57*

5.67 ± 0.30

4.83 ± 0.21

6.31 ± 0.84

Stiffness

4.35 ± 0.20

6.68 ± 0.97*

12.20 ± 2.50**

10.13 ± 1.44**

7.64 ± 0.93**

CAP

222.83 ± 7.98

280.42 ± 10.56**

314.97 ± 9.27**

241.43 ± 12.84

274.93 ± 12.38**

  1. Notes: Data are expressed as mean ± SEM
  2. *:P < 0.05, **: P <0.01 vs control group